Concepedia

Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis

Jovan Borjan, Kevin A. Meyer, Ryan K. Shields, Eric Wenzler

International Journal of Antimicrobial Agents · 2019 · 26 citations · 22 references

DOI

Concepts

References

22

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

David van Duin, Judith J. Lok, Michelle Earley et al. · Clinical Infectious Diseases · 2017 · 652 citations · Full text

, , +16

Positive Correlation between Virulence of <i>Pseudomonas aeruginosa</i> Mutants in Mice and Insects

Georg Jander, Laurence G. Rahme, Frederick M. Ausubel · Journal of Bacteriology · 2000 · 534 citations · Full text

, , +17

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Ryan K. Shields, M. Hong Nguyen, Liang Chen et al. · Antimicrobial Agents and Chemotherapy · 2017 · 487 citations · Full text

, , +13

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne <i>bla</i> <sub>KPC-3</sub> Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

Ryan K. Shields, Liang Chen, Shaoji Cheng et al. · Antimicrobial Agents and Chemotherapy · 2016 · 485 citations · Full text

, , +17

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Ryan K. Shields, Brian A. Potoski, Ghady Haidar et al. · Clinical Infectious Diseases · 2016 · 428 citations · Full text

, , +17